Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Puma Biotechnology, Inc.

Clinical trials sponsored by Puma Biotechnology, Inc., explained in plain language.

Puma Biotechnology, Inc. PBYI NASDAQ

A biopharmaceutical company focused on developing and commercializing cancer therapies.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet recruiting 1

New drug combo aims to tame tough lung cancer

Disease control Not yet recruiting

This study tests a new drug combination (alisertib plus paclitaxel) in people with small cell lung cancer who have already tried other treatments. The main goal is to find safe doses and see what side effects occur. About 50 adults will take alisertib pills and receive paclitaxel…

Phase: PHASE2 • Sponsor: Puma Biotechnology, Inc. • Aim: Disease control

Last updated Jun 27, 2026 11:01 UTC